Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087275110> ?p ?o ?g. }
- W2087275110 abstract "We have recently documented the spontaneous development of a mouse pituitary tumor line (MGH 101A) secreting only the alpha-subunit of the glycoprotein hormones. Secretion of alpha-subunit by MGH 101A was not inhibited by either physiological or pharmacological levels of thyroid hormones. The present study demonstrates that combined treatment with bromocriptine and pharmacological doses of T4 for 1 month significantly decreased both tumor growth and alpha-subunit secretion of MGH 101A in thyroidectomized host mice. Either treatment alone was ineffective. The fall in plasma alpha-subunit concentrations after the combined treatment was probably due to the inhibition of tumor growth, since the decreases in plasma alpha-subunit levels and tumor weights were quantitatively similar, and there was no significant change in tumor steady state concentrations of alpha-subunit mRNA. In two of three experiments, the combined treatment resulted in a significant fall in tumor total DNA concentrations; this suggests that decreased tumor growth was at least in part due to inhibition of tumor cell replication. To compare the effects of the various treatments on the pure alpha-subunit-producing pituitary tumor with their effects on non-tumorous pituitary, we also measured secretion of TSH and PRL into plasma by the host pituitary. Treatment with T4 alone profoundly suppressed plasma concentrations of TSH and significantly reduced plasma PRL levels compared to levels in the thyroidectomized controls. Surprisingly, both thyroidectomized and euthyroid tumor hosts treated with bromocriptine alone showed no suppression of plasma PRL levels. However, combined treatment with bromocriptine and pharmacological doses of T4 resulted in plasma PRL concentrations significantly lower than those after treatment with T4 alone. Thus, the tumor and nontumorous host pituitaries differed in their responses to T4 alone. However, the two tissues were similar in their responses to bromocriptine alone and to combined treatment with bromocriptine and T4. We conclude that combined treatment with T4 and bromocriptine inhibited the growth and secretion of the pure alpha-subunit-secreting tumor MGH 101A. The data on PRL secretion by the host pituitary suggest that T4 may have acted by enhancing the function of dopamine receptors." @default.
- W2087275110 created "2016-06-24" @default.
- W2087275110 creator A5004522280 @default.
- W2087275110 creator A5009871956 @default.
- W2087275110 creator A5047744163 @default.
- W2087275110 creator A5084642276 @default.
- W2087275110 date "1985-10-01" @default.
- W2087275110 modified "2023-09-24" @default.
- W2087275110 title "Pure α-Subunit-Secreting Mouse Pituitary Tumor: Inhibition of Growth and Secretion by Combined Treatment with Thyroxine and Bromocriptine*" @default.
- W2087275110 cites W1519761239 @default.
- W2087275110 cites W1537146606 @default.
- W2087275110 cites W1537716625 @default.
- W2087275110 cites W1554082381 @default.
- W2087275110 cites W1775749144 @default.
- W2087275110 cites W182473277 @default.
- W2087275110 cites W1966674534 @default.
- W2087275110 cites W1972540442 @default.
- W2087275110 cites W1977779461 @default.
- W2087275110 cites W1981320875 @default.
- W2087275110 cites W1991956116 @default.
- W2087275110 cites W1996024100 @default.
- W2087275110 cites W1999381294 @default.
- W2087275110 cites W2002080056 @default.
- W2087275110 cites W2002940354 @default.
- W2087275110 cites W2014029636 @default.
- W2087275110 cites W2015646812 @default.
- W2087275110 cites W2016490618 @default.
- W2087275110 cites W2020317858 @default.
- W2087275110 cites W2021550031 @default.
- W2087275110 cites W2025137928 @default.
- W2087275110 cites W2031192188 @default.
- W2087275110 cites W2031777684 @default.
- W2087275110 cites W2037181144 @default.
- W2087275110 cites W2055144184 @default.
- W2087275110 cites W2059926505 @default.
- W2087275110 cites W2060333964 @default.
- W2087275110 cites W2075707756 @default.
- W2087275110 cites W2077038515 @default.
- W2087275110 cites W2079949053 @default.
- W2087275110 cites W2082465748 @default.
- W2087275110 cites W2083099625 @default.
- W2087275110 cites W2085121249 @default.
- W2087275110 cites W2087428465 @default.
- W2087275110 cites W2090664922 @default.
- W2087275110 cites W2106613586 @default.
- W2087275110 cites W2123715993 @default.
- W2087275110 cites W2126834795 @default.
- W2087275110 cites W2153291638 @default.
- W2087275110 cites W2164262896 @default.
- W2087275110 cites W2414501657 @default.
- W2087275110 doi "https://doi.org/10.1210/endo-117-4-1418" @default.
- W2087275110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2411527" @default.
- W2087275110 hasPublicationYear "1985" @default.
- W2087275110 type Work @default.
- W2087275110 sameAs 2087275110 @default.
- W2087275110 citedByCount "3" @default.
- W2087275110 crossrefType "journal-article" @default.
- W2087275110 hasAuthorship W2087275110A5004522280 @default.
- W2087275110 hasAuthorship W2087275110A5009871956 @default.
- W2087275110 hasAuthorship W2087275110A5047744163 @default.
- W2087275110 hasAuthorship W2087275110A5084642276 @default.
- W2087275110 hasConcept C104292427 @default.
- W2087275110 hasConcept C104317684 @default.
- W2087275110 hasConcept C126322002 @default.
- W2087275110 hasConcept C134018914 @default.
- W2087275110 hasConcept C185592680 @default.
- W2087275110 hasConcept C2776856834 @default.
- W2087275110 hasConcept C2777195454 @default.
- W2087275110 hasConcept C2777658017 @default.
- W2087275110 hasConcept C2779064019 @default.
- W2087275110 hasConcept C2781449511 @default.
- W2087275110 hasConcept C49039625 @default.
- W2087275110 hasConcept C55493867 @default.
- W2087275110 hasConcept C71315377 @default.
- W2087275110 hasConcept C71924100 @default.
- W2087275110 hasConcept C83730767 @default.
- W2087275110 hasConcept C86803240 @default.
- W2087275110 hasConceptScore W2087275110C104292427 @default.
- W2087275110 hasConceptScore W2087275110C104317684 @default.
- W2087275110 hasConceptScore W2087275110C126322002 @default.
- W2087275110 hasConceptScore W2087275110C134018914 @default.
- W2087275110 hasConceptScore W2087275110C185592680 @default.
- W2087275110 hasConceptScore W2087275110C2776856834 @default.
- W2087275110 hasConceptScore W2087275110C2777195454 @default.
- W2087275110 hasConceptScore W2087275110C2777658017 @default.
- W2087275110 hasConceptScore W2087275110C2779064019 @default.
- W2087275110 hasConceptScore W2087275110C2781449511 @default.
- W2087275110 hasConceptScore W2087275110C49039625 @default.
- W2087275110 hasConceptScore W2087275110C55493867 @default.
- W2087275110 hasConceptScore W2087275110C71315377 @default.
- W2087275110 hasConceptScore W2087275110C71924100 @default.
- W2087275110 hasConceptScore W2087275110C83730767 @default.
- W2087275110 hasConceptScore W2087275110C86803240 @default.
- W2087275110 hasLocation W20872751101 @default.
- W2087275110 hasLocation W20872751102 @default.
- W2087275110 hasOpenAccess W2087275110 @default.
- W2087275110 hasPrimaryLocation W20872751101 @default.
- W2087275110 hasRelatedWork W1966296538 @default.
- W2087275110 hasRelatedWork W2019154672 @default.
- W2087275110 hasRelatedWork W2020367384 @default.